Surgery Open Science (Jul 2022)

New chronic opioid use in Medicaid patients following cholecystectomy

  • Mark A Lockett, MD,
  • Ralph C Ward, PhD,
  • Jenna L McCauley, PhD,
  • David J Taber, PharmD,
  • Mulugeta Gebregziabher, PhD,
  • Robert A Cina, MD,
  • William T Basco, Jr, MD,
  • Patrick D. Mauldin, PhD,
  • Sarah J Ball, PharmD

Journal volume & issue
Vol. 9
pp. 101 – 108

Abstract

Read online

Background: Commercial insurance data show that chronic opioid use in opioid-naive patients occurs in 1.5% to 8% of patients undergoing surgical procedures, but little is known about patients with Medicaid. Methods: Opioid prescription data and medical coding data from 4,788 Medicaid patients who underwent cholecystectomy were analyzed to determine opioid use patterns. Results: A total of 54.4% of patients received opioids prior to surgery, and 38.8% continued to fill opioid prescriptions chronically; 27.1% of opioid-naive patients continued to get opioids chronically. Patients who received ≥50 MME/d had nearly 8 times the odds of chronic opioid use. Each additional opioid prescription filled within 30 days was associated with increased odds of chronic use (odds ratio: 1.71). Conclusion: Opioid prescriptions are common prior to cholecystectomy in Medicaid patients, and 38.8% of patients continue to receive opioid prescriptions well after surgical recovery. Even 27.1% of opioid-naive patients continued to receive opioid prescriptions chronically.